John Farah
Director/Board Member at AEOLUS PHARMACEUTICALS, INC.
Net worth: 1 339 $ as of 2024-06-29
John Farah active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 2005-10-23 | - |
| Independent Dir/Board Member | 2011-05-22 | - | |
| POND TECHNOLOGIES HOLDINGS INC. | Director/Board Member | 2021-07-13 | - |
Career history of John Farah
Former positions of John Farah
| Companies | Position | Start | End |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 1992-09-30 | - |
| REBUS HOLDINGS, INC. | Director/Board Member | 2008-01-31 | 2010-08-16 |
| Independent Dir/Board Member | 2008-01-31 | 2010-08-16 | |
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Director/Board Member | 2013-01-10 | 2013-01-15 |
| Independent Dir/Board Member | 2013-01-10 | 2013-01-15 | |
| Corporate Officer/Principal | 2013-01-15 | - | |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Chief Tech/Sci/R&D Officer | - | - |
Training of John Farah
| University of Maryland | Undergraduate Degree |
| New College of California | Undergraduate Degree |
| Uniformed Services University of the Health Sciences | Doctorate Degree |
Statistics
International
| United States | 9 |
| Canada | 2 |
Operational
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Undergraduate Degree | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| POND TECHNOLOGIES HOLDINGS INC. | Health Technology |
| Private companies | 3 |
|---|---|
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
- Stock Market
- Insiders
- John Farah
- Experience
